← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Potassio canrenoato currently has availability issues reported in 1 European register: Italy.
Shortage ATC — · also listed as: POTASSIO CANRENOATO · data refreshed 9 September 2026
As of 9 September 2026, 1 of the 9 tracked registers list current availability issues for Potassio canrenoato, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2025-07-01 and has now been open for about 14 months. Where agencies state a cause, manufacturing problems lead with 1 of the 2 stated-cause reports, followed by commercial decisions or discontinuation with 1. The furthest expected-resolution date currently on file is 2027-02-26; the earliest is 2027-02-26. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇮🇹 Italy | Shortage KANRENOL + 1 more productsPOTASSIO CANRENOATO PENSA | 2025-07-01 | 2027-02-26 | Problemi produttivi: distribuzione contingentata (carenza relativa solo al canale ospedaliero) Alternatives: AIFA: import of a foreign equivalent can be authorised. | register ↗ |
Every individual register entry for Potassio canrenoato in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | KANRENOL | Shortage | 2025-10-01 | 2027-02-26 | Problemi produttivi: distribuzione contingentata (carenza re |
| 🇮🇹 IT | POTASSIO CANRENOATO PENSA | Shortage | 2025-07-01 | — | Cessata commercializzazione temporanea |
Yes. As of 9 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2027-02-26 to 2027-02-26. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency register that lists Potassio canrenoato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Potassio canrenoato — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/potassio-canrenoato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Potassio canrenoato availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/potassio-canrenoato/">Potassio canrenoato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>